| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
28,819 |
21,042 |
$2.99M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18,552 |
13,852 |
$2.06M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,764 |
7,646 |
$1.70M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,490 |
2,044 |
$588K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,571 |
6,011 |
$456K |
| 80053 |
Comprehensive metabolic panel |
22,331 |
18,020 |
$285K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,079 |
1,944 |
$153K |
| S5161 |
Emergency response system; service fee, per month (excludes installation and testing) |
3,163 |
2,771 |
$119K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,959 |
1,660 |
$99K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,283 |
1,115 |
$78K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
887 |
707 |
$61K |
| S5185 |
Medication reminder service, non-face-to-face; per month |
1,023 |
857 |
$57K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,079 |
1,944 |
$51K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
409 |
311 |
$49K |
| 81003 |
|
1,599 |
1,083 |
$45K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,930 |
453 |
$42K |
| 87400 |
|
2,946 |
1,914 |
$41K |
| 80320 |
|
334 |
297 |
$34K |
| A0425 |
Ground mileage, per statute mile |
2,170 |
1,606 |
$28K |
| 83605 |
|
1,634 |
1,232 |
$21K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
217 |
137 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
761 |
741 |
$18K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,809 |
18,411 |
$17K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
72 |
63 |
$15K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
438 |
344 |
$14K |
| 70450 |
Computed tomography, head or brain; without contrast material |
89 |
62 |
$13K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
232 |
194 |
$12K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
29 |
26 |
$11K |
| 84484 |
|
793 |
571 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
234 |
222 |
$7K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
17 |
13 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,967 |
3,975 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
499 |
454 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,400 |
2,127 |
$5K |
| 87088 |
|
198 |
175 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
108 |
105 |
$5K |
| 80061 |
Lipid panel |
329 |
294 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
162 |
136 |
$4K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
164 |
81 |
$4K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
20 |
12 |
$3K |
| 81025 |
|
210 |
198 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
27 |
24 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,554 |
1,851 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
108 |
105 |
$2K |
| 84439 |
|
169 |
155 |
$2K |
| 81001 |
|
5,461 |
4,673 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
497 |
396 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
15 |
15 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
60 |
49 |
$907.72 |
| S5160 |
Emergency response system; installation and testing |
31 |
14 |
$845.00 |
| 83690 |
|
3,153 |
2,645 |
$734.14 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
18 |
12 |
$720.48 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
242 |
187 |
$709.97 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
300 |
293 |
$709.65 |
| 86593 |
|
24 |
24 |
$653.82 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,413 |
1,107 |
$639.27 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
55 |
50 |
$598.96 |
| A9270 |
Non-covered item or service |
14,460 |
9,422 |
$570.70 |
| 87641 |
|
16 |
13 |
$536.22 |
| 85027 |
|
244 |
199 |
$468.43 |
| 86592 |
|
37 |
37 |
$468.20 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
57 |
53 |
$467.62 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
13 |
12 |
$407.05 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
12 |
12 |
$369.36 |
| 85018 |
|
24 |
24 |
$358.14 |
| 86803 |
|
12 |
12 |
$330.97 |
| 71046 |
Radiologic examination, chest; 2 views |
677 |
566 |
$329.41 |
| 87081 |
|
60 |
52 |
$327.71 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,055 |
843 |
$294.81 |
| 87640 |
|
16 |
13 |
$269.64 |
| J2704 |
Injection, propofol, 10 mg |
921 |
729 |
$253.13 |
| 97161 |
|
12 |
12 |
$152.80 |
| 86850 |
|
17 |
13 |
$144.48 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
357 |
260 |
$127.46 |
| 83735 |
|
690 |
539 |
$53.91 |
| 86901 |
|
17 |
13 |
$52.02 |
| 86900 |
|
17 |
13 |
$26.01 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,106 |
931 |
$19.82 |
| 85610 |
|
162 |
133 |
$15.99 |
| 86140 |
|
158 |
127 |
$9.26 |
| 71045 |
Radiologic examination, chest; single view |
155 |
121 |
$6.57 |
| 85730 |
|
77 |
64 |
$5.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
47 |
36 |
$0.00 |
| 84703 |
|
13 |
13 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
287 |
243 |
$0.00 |
| 81015 |
|
32 |
31 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
19 |
12 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
20 |
12 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
20 |
12 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21 |
20 |
$0.00 |
| 80305 |
|
201 |
171 |
$0.00 |